PMVP vs. MO
PMVP (PMV Pharmaceuticals, Inc.) and MO (Altria Group, Inc.) are both stocks. PMVP operates in Biotechnology (Healthcare), while MO operates in Tobacco (Consumer Defensive). Over the past 5 years, PMVP returned -50.16%/yr vs 16.39%/yr for MO. Their 0.00 correlation means their historical movements had little consistent relationship.
Performance
PMVP vs. MO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PMVP achieves a -10.40% return, which is significantly lower than MO's 22.17% return.
PMVP
- 1D
- 0.90%
- 1M
- -8.20%
- 6M
- 5.66%
- YTD
- -10.40%
- 1Y
- -20.00%
- 3Y*
- -44.64%
- 5Y*
- -50.16%
- 10Y*
- —
- ALL TIME*
- -44.46%
MO
- 1D
- -0.10%
- 1M
- -6.12%
- 6M
- 13.20%
- YTD
- 22.17%
- 1Y
- 17.98%
- 3Y*
- 24.93%
- 5Y*
- 16.39%
- 10Y*
- 7.33%
- ALL TIME*
- 17.80%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $656.06M | $570.37M | $589.44M | |
| $494.13K | $487.49K | $457.02K |
PMVP vs. MO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PMVP PMV Pharmaceuticals, Inc. | -10.40% | -17.22% | -51.29% | -64.37% | -62.34% | -62.45% | 75.74% |
MO Altria Group, Inc. | 22.17% | 18.17% | 40.76% | -3.70% | 4.37% | 24.18% | 9.16% |
Correlation
The correlation between PMVP and MO is -0.13, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.13 |
Correlation (3Y) Balances recent behavior with more history. | -0.02 |
Correlation (5Y) Shows whether the relationship held over a longer period. | -0.00 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2020 | 0.00 |
The correlation between PMVP and MO shifts across timeframes, from -0.13 (1 year) to 0.00 (all time), reflecting how their relationship changes across market environments.
Fundamentals
PMVP:
$59.73M
MO:
$113.98B
PMVP:
-$1.47
MO:
$4.76
PMVP:
$0.00
MO:
$21.87B
PMVP:
-$97.00K
MO:
$15.52B
PMVP:
-$80.43M
MO:
$11.75B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PMVP vs. MO — Risk / Return Rank
PMVP
MO
PMVP vs. MO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for PMV Pharmaceuticals, Inc. (PMVP) and Altria Group, Inc. (MO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PMVP | MO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.01 | ||
| Sortino ratioReturn per unit of downside risk | -1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.16 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | 1.10 | -1.58 |
| Martin ratioReturn relative to average drawdown | -0.84 | 2.73 | -3.56 |
Loading charts...
Drawdowns
PMVP vs. MO - Drawdown Comparison
The maximum PMVP drawdown since its inception was -98.64%, which is greater than MO's maximum drawdown of -65.43%. Use the drawdown chart below to compare losses from any high point for PMVP and MO.
Loading charts...
Drawdown Indicators
| PMVP | MO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.64% | -65.43% | -33.21% |
Max Drawdown (1Y)Largest decline over 1 year | -41.67% | -16.40% | -25.27% |
Max Drawdown (3Y)Largest decline over 3 years | -90.61% | -16.40% | -74.21% |
Max Drawdown (5Y)Largest decline over 5 years | -97.71% | -25.83% | -71.88% |
Max Drawdown (10Y)Largest decline over 10 years | — | -53.69% | — |
Current DrawdownCurrent decline from peak | -98.18% | -8.89% | -89.29% |
Average DrawdownAverage peak-to-trough decline | -80.21% | -11.90% | -68.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.89% | 6.61% | +17.28% |
Volatility
PMVP vs. MO - Volatility Comparison
PMV Pharmaceuticals, Inc. (PMVP) has a higher volatility of 20.09% compared to Altria Group, Inc. (MO) at 11.98%. This indicates that PMVP's price experiences larger fluctuations and is considered to be riskier than MO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PMVP | MO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.09% | 11.98% | +8.11% |
Volatility (6M)Calculated over the trailing 6-month period | 51.64% | 19.80% | +31.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.30% | 25.01% | +46.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.94% | 21.28% | +55.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 76.86% | 23.29% | +53.57% |
Dividends
PMVP vs. MO - Dividend Comparison
PMVP has not paid dividends to shareholders, while MO's dividend yield for the trailing twelve months is around 6.21%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MO Altria Group, Inc. | 6.21% | 7.21% | 7.65% | 9.52% | 8.05% | 7.43% | 8.29% | 6.57% | 6.07% | 3.56% | 3.48% | 3.73% |
PMVP PMV Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
PMVP vs. MO - Financials Comparison
This section allows you to compare key financial metrics between PMV Pharmaceuticals, Inc. and Altria Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PMVP and MO have a correlation of -0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PMVP has higher volatility (20.09%) compared to MO (11.98%). In terms of maximum drawdown, PMVP dropped -98.64% vs MO's -65.43%.
MO currently has the higher Sharpe Ratio (0.72 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PMVP and MO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer